Report : South America Nasal Irrigation Devices Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Manual Nasal Irrigators, Electric Nasal Irrigators, and Battery Powered Nasal Irrigators), Patient Type (Pediatrics and Adult), Application (Rhinitis, Sinus, Bronchiolitis, Post-Operative Respiratory Conditions, and Others), and End User (Hospitals & Clinics, Home Care, and Others)
At 17.1% CAGR, the South America Nasal Irrigation Devices Market is speculated to be worth US$ 72.60 million by 2028, says Business Market Insights
According to Business Market Insights’ research, the South America nasal irrigation devices market was valued at US$ 28.12 million in 2022 and is expected to reach US$ 72.60 million by 2028, registering a CAGR of 17.1% from 2022 to 2028. Increase in allergies and infectious diseases and increasing awareness among patients and benefits offered by nasal irrigation are the critical factors attributed to the South America nasal irrigation devices expansion.
Nasal irrigation is the practice of upper respiratory tract care that originated from traditional ayurvedic medicine, which was later adopted by western medicine and gained popularity on a South America level. Nasal irrigation therapy is combined with other therapies for improved efficiency and speedy recovery. It is one of the most common methods used to relieve congestion of the nasal passage and treat various nasal infections caused by pollution, allergies, and pollens. The increasing prevalence of nasal allergies and sinus infections has created the demand for nasal irrigation, which in turn has driven the growth of the nasal irrigation devices market. Nasal irrigation has several benefits, such as washing allergens away, pulling out fluid, improving breathing, clearing sinuses passage, and many more. Of late, the awareness regarding these benefits has increased among consumers, translating into high demand for nasal irrigation devices, aiding the market. This is expected to drive the South America nasal irrigation devices during the forecast period.
On the contrary, challenges associated with nasal irrigation devices hurdles the growth of South America nasal irrigation devices market.
Based on product type, the South America nasal irrigation devices market is categorized into manual nasal irrigators, electric nasal irrigators, and battery powered nasal irrigators. The manual nasal irrigators segment held 46.3% market share in 2022, amassing US$ 13.02 million. It is projected to garner US$ 32.42 million by 2028 to expand at 16.4% CAGR during 2022–2028.
Based on patient type, the South America nasal irrigation devices market is bifurcated into pediatrics and adult. The adult segment held 58.8% market share in 2022, amassing US$ 16.54 million. It is projected to garner US$ 43.67 million by 2028 to expand at 17.6% CAGR during 2022–2028.
Based on application, the South America nasal irrigation devices market is categorized into rhinitis, sinus, bronchiolitis, post-operative respiratory conditions, and others. The sinus segment held 31.5% market share in 2022, amassing US$ 8.87 million. It is projected to garner US$ 23.69 million by 2028 to expand at 17.8% CAGR during 2022–2028.
Based on end user, the South America nasal irrigation devices market is categorized into hospitals & clinics, home care, and others. The home care segment held 39.4% of the South America nasal irrigation devices share in 2022, amassing US$ 11.08 million. It is projected to garner US$ 29.58 million by 2028 to expand at 17.8% CAGR during 2022–2028.
Based on country, the South America nasal irrigation devices market has been categorized into the Brazil, Argentina, and the Rest of South America. Our regional analysis states that Brazil captured 55.3% market share in 2022. It was assessed at US$ 15.54 million in 2022 and is likely to hit US$ 41.91 million by 2028, exhibiting a CAGR of 18.0% during the forecast period.
Key players dominating the South America nasal irrigation devices market are Air Liquide Medical Systems; Neilmed Pharmaceuticals Inc.; Stryker Corp; Medtronic Plc; and Bayer AG among others.
- In May 2022, Medtronic completes acquisition of Intersect ENT.
- In June 2019, Air Liquide reinforces its presence in South America with the acquisition of Medidis in the Netherlands.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com